Medical Care
Global Nitric Oxide Therapy System Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301189
- Pages: 135
- Figures: 143
- Views: 4
In 2024, the global market size of Nitric Oxide Therapy System was estimated to be worth US$ 35.5 million and is forecast to reach approximately US$ 51.1 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nitric Oxide Therapy System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitric Oxide Therapy System.
The Nitric Oxide Therapy System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nitric Oxide Therapy System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitric Oxide Therapy System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Segment by Type
Protable System
Fixed System
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Nitric Oxide Therapy System in global and regional level.
Chapter 3: Detailed analysis of Nitric Oxide Therapy System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nitric Oxide Therapy System revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nitric Oxide Therapy System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitric Oxide Therapy System.
The Nitric Oxide Therapy System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nitric Oxide Therapy System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitric Oxide Therapy System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Segment by Type
Protable System
Fixed System
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Nitric Oxide Therapy System in global and regional level.
Chapter 3: Detailed analysis of Nitric Oxide Therapy System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nitric Oxide Therapy System revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Nitric Oxide Therapy System Product Introduction
1.2 Market by Type
1.2.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Protable System
1.2.3 Fixed System
1.3 Market by Application
1.3.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nitric Oxide Therapy System Market Size Estimates and Forecasts
2.2 Nitric Oxide Therapy System Market Size by Region: 2024 Versus 2031
2.2.1 Global Nitric Oxide Therapy System Revenue by Region: 2020-2025
2.2.2 Global Nitric Oxide Therapy System Revenue Forecast by Region (2026-2031)
2.2.3 Global Nitric Oxide Therapy System Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Nitric Oxide Therapy System Revenue by Type (2020-2031)
3.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Nitric Oxide Therapy System Revenue by Application (2020-2031)
3.2.2 Global Nitric Oxide Therapy System Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Protable System of Nitric Oxide Therapy System Revenue Market Share by Application
3.3.2 Fixed System of Nitric Oxide Therapy System Revenue Market Share by Application
4 Global Nitric Oxide Therapy System by Company
4.1 Global Nitric Oxide Therapy System Revenue by Company (2020-2025)
4.2 Global Nitric Oxide Therapy System Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Nitric Oxide Therapy System Companies around the World: Ranking by Revenue
4.3.2 Global Nitric Oxide Therapy System Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Nitric Oxide Therapy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Nitric Oxide Therapy System Companies Headquarters & Product Type
4.4.1 Global Nitric Oxide Therapy System Companies Headquarters
4.4.2 Date of International Companies Enter into Nitric Oxide Therapy System Market
4.4.3 Global Nitric Oxide Therapy System Companies Product & Service
4.4.4 Protable System Revenue Market Share of Nitric Oxide Therapy System by Company
4.4.5 Fixed System Revenue Market Share of Nitric Oxide Therapy System by Company
4.5 Global Nitric Oxide Therapy System Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bellerophon Therapeutics
5.1.1 Bellerophon Therapeutics Corporation Information
5.1.2 Bellerophon Therapeutics Description, Business Overview
5.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Products Offered
5.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.1.5 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue by Product in 2024
5.1.6 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue by Application in 2024
5.1.7 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.1.8 Bellerophon Therapeutics Recent Developments
5.2 BOC Healthcare
5.2.1 BOC Healthcare Corporation Information
5.2.2 BOC Healthcare Description, Business Overview
5.2.3 BOC Healthcare Nitric Oxide Therapy System Products Offered
5.2.4 BOC Healthcare Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.2.5 BOC Healthcare Nitric Oxide Therapy System Revenue by Product in 2024
5.2.6 BOC Healthcare Nitric Oxide Therapy System Revenue by Application in 2024
5.2.7 BOC Healthcare Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.2.8 BOC Healthcare Recent Developments
5.3 Dan Hammer Health
5.3.1 Dan Hammer Health Corporation Information
5.3.2 Dan Hammer Health Description, Business Overview
5.3.3 Dan Hammer Health Nitric Oxide Therapy System Products Offered
5.3.4 Dan Hammer Health Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.3.5 Dan Hammer Health Nitric Oxide Therapy System Revenue by Product in 2024
5.3.6 Dan Hammer Health Nitric Oxide Therapy System Revenue by Application in 2024
5.3.7 Dan Hammer Health Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.3.8 Dan Hammer Health Recent Developments
5.4 EKU Elektronik GmbH
5.4.1 EKU Elektronik GmbH Corporation Information
5.4.2 EKU Elektronik GmbH Description, Business Overview
5.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Products Offered
5.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.4.5 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue by Product in 2024
5.4.6 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue by Application in 2024
5.4.7 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.4.8 EKU Elektronik GmbH Recent Developments
5.5 GeNO LLC
5.5.1 GeNO LLC Corporation Information
5.5.2 GeNO LLC Description, Business Overview
5.5.3 GeNO LLC Nitric Oxide Therapy System Products Offered
5.5.4 GeNO LLC Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.5.5 GeNO LLC Nitric Oxide Therapy System Revenue by Product in 2024
5.5.6 GeNO LLC Nitric Oxide Therapy System Revenue by Application in 2024
5.5.7 GeNO LLC Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.5.8 GeNO LLC Recent Developments
5.6 International Biomedical
5.6.1 International Biomedical Corporation Information
5.6.2 International Biomedical Description, Business Overview
5.6.3 International Biomedical Nitric Oxide Therapy System Products Offered
5.6.4 International Biomedical Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.6.5 International Biomedical Nitric Oxide Therapy System Revenue by Product in 2024
5.6.6 International Biomedical Nitric Oxide Therapy System Revenue by Application in 2024
5.6.7 International Biomedical Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.6.8 International Biomedical Recent Developments
5.7 SLE
5.7.1 SLE Corporation Information
5.7.2 SLE Description, Business Overview
5.7.3 SLE Nitric Oxide Therapy System Products Offered
5.7.4 SLE Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.7.5 SLE Nitric Oxide Therapy System Revenue by Product in 2024
5.7.6 SLE Nitric Oxide Therapy System Revenue by Application in 2024
5.7.7 SLE Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.7.8 SLE Recent Developments
5.8 Mallinckrodt Pharmaceuticals
5.8.1 Mallinckrodt Pharmaceuticals Corporation Information
5.8.2 Mallinckrodt Pharmaceuticals Description, Business Overview
5.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Products Offered
5.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.8.5 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue by Product in 2024
5.8.6 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue by Application in 2024
5.8.7 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.8.8 Mallinckrodt Pharmaceuticals Recent Developments
5.9 Praxair,
5.9.1 Praxair, Corporation Information
5.9.2 Praxair, Description, Business Overview
5.9.3 Praxair, Nitric Oxide Therapy System Products Offered
5.9.4 Praxair, Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.9.5 Praxair, Nitric Oxide Therapy System Revenue by Product in 2024
5.9.6 Praxair, Nitric Oxide Therapy System Revenue by Application in 2024
5.9.7 Praxair, Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.9.8 Praxair, Recent Developments
5.10 Vapotherm
5.10.1 Vapotherm Corporation Information
5.10.2 Vapotherm Description, Business Overview
5.10.3 Vapotherm Nitric Oxide Therapy System Products Offered
5.10.4 Vapotherm Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.10.5 Vapotherm Nitric Oxide Therapy System Revenue by Product in 2024
5.10.6 Vapotherm Nitric Oxide Therapy System Revenue by Application in 2024
5.10.7 Vapotherm Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.10.8 Vapotherm Recent Developments
5.11 Linde Group
5.11.1 Linde Group Corporation Information
5.11.2 Linde Group Description, Business Overview
5.11.3 Linde Group Nitric Oxide Therapy System Products Offered
5.11.4 Linde Group Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.11.5 Linde Group Nitric Oxide Therapy System Revenue by Product in 2024
5.11.6 Linde Group Nitric Oxide Therapy System Revenue by Application in 2024
5.11.7 Linde Group Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.11.8 Linde Group Recent Developments
6 North America
6.1 North America Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
6.2 North America Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
6.3 North America Nitric Oxide Therapy System Revenue by Type (2020-2025)
6.4 North America Nitric Oxide Therapy System Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Nitric Oxide Therapy System Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Nitric Oxide Therapy System Revenue by Type (2020-2025)
7.4 Asia-Pacific Nitric Oxide Therapy System Revenue by Application (2020-2025)
8 Europe
8.1 Europe Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
8.2 Europe Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
8.3 Europe Nitric Oxide Therapy System Revenue by Type (2020-2025)
8.4 Europe Nitric Oxide Therapy System Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
9.2 Latin America Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
9.3 Latin America Nitric Oxide Therapy System Revenue by Type (2020-2025)
9.4 Latin America Nitric Oxide Therapy System Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Nitric Oxide Therapy System Revenue by Type (2020-2025)
10.4 Middle East and Africa Nitric Oxide Therapy System Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Nitric Oxide Therapy System Supply Chain Analysis
11.2 Nitric Oxide Therapy System Key Raw Materials and Upstream Suppliers
11.3 Nitric Oxide Therapy System Clients Analysis
11.4 Nitric Oxide Therapy System Sales Channel and Sales Model Analysis
11.4.1 Nitric Oxide Therapy System Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Nitric Oxide Therapy System Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Nitric Oxide Therapy System Distributors
12 Nitric Oxide Therapy System Market Dynamics
12.1 Nitric Oxide Therapy System Industry Trends
12.2 Nitric Oxide Therapy System Market Drivers
12.3 Nitric Oxide Therapy System Market Challenges
12.4 Nitric Oxide Therapy System Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Nitric Oxide Therapy System Product Introduction
1.2 Market by Type
1.2.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Protable System
1.2.3 Fixed System
1.3 Market by Application
1.3.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nitric Oxide Therapy System Market Size Estimates and Forecasts
2.2 Nitric Oxide Therapy System Market Size by Region: 2024 Versus 2031
2.2.1 Global Nitric Oxide Therapy System Revenue by Region: 2020-2025
2.2.2 Global Nitric Oxide Therapy System Revenue Forecast by Region (2026-2031)
2.2.3 Global Nitric Oxide Therapy System Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Nitric Oxide Therapy System Revenue by Type (2020-2031)
3.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Nitric Oxide Therapy System Revenue by Application (2020-2031)
3.2.2 Global Nitric Oxide Therapy System Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Protable System of Nitric Oxide Therapy System Revenue Market Share by Application
3.3.2 Fixed System of Nitric Oxide Therapy System Revenue Market Share by Application
4 Global Nitric Oxide Therapy System by Company
4.1 Global Nitric Oxide Therapy System Revenue by Company (2020-2025)
4.2 Global Nitric Oxide Therapy System Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Nitric Oxide Therapy System Companies around the World: Ranking by Revenue
4.3.2 Global Nitric Oxide Therapy System Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Nitric Oxide Therapy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Nitric Oxide Therapy System Companies Headquarters & Product Type
4.4.1 Global Nitric Oxide Therapy System Companies Headquarters
4.4.2 Date of International Companies Enter into Nitric Oxide Therapy System Market
4.4.3 Global Nitric Oxide Therapy System Companies Product & Service
4.4.4 Protable System Revenue Market Share of Nitric Oxide Therapy System by Company
4.4.5 Fixed System Revenue Market Share of Nitric Oxide Therapy System by Company
4.5 Global Nitric Oxide Therapy System Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bellerophon Therapeutics
5.1.1 Bellerophon Therapeutics Corporation Information
5.1.2 Bellerophon Therapeutics Description, Business Overview
5.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Products Offered
5.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.1.5 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue by Product in 2024
5.1.6 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue by Application in 2024
5.1.7 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.1.8 Bellerophon Therapeutics Recent Developments
5.2 BOC Healthcare
5.2.1 BOC Healthcare Corporation Information
5.2.2 BOC Healthcare Description, Business Overview
5.2.3 BOC Healthcare Nitric Oxide Therapy System Products Offered
5.2.4 BOC Healthcare Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.2.5 BOC Healthcare Nitric Oxide Therapy System Revenue by Product in 2024
5.2.6 BOC Healthcare Nitric Oxide Therapy System Revenue by Application in 2024
5.2.7 BOC Healthcare Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.2.8 BOC Healthcare Recent Developments
5.3 Dan Hammer Health
5.3.1 Dan Hammer Health Corporation Information
5.3.2 Dan Hammer Health Description, Business Overview
5.3.3 Dan Hammer Health Nitric Oxide Therapy System Products Offered
5.3.4 Dan Hammer Health Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.3.5 Dan Hammer Health Nitric Oxide Therapy System Revenue by Product in 2024
5.3.6 Dan Hammer Health Nitric Oxide Therapy System Revenue by Application in 2024
5.3.7 Dan Hammer Health Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.3.8 Dan Hammer Health Recent Developments
5.4 EKU Elektronik GmbH
5.4.1 EKU Elektronik GmbH Corporation Information
5.4.2 EKU Elektronik GmbH Description, Business Overview
5.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Products Offered
5.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.4.5 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue by Product in 2024
5.4.6 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue by Application in 2024
5.4.7 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.4.8 EKU Elektronik GmbH Recent Developments
5.5 GeNO LLC
5.5.1 GeNO LLC Corporation Information
5.5.2 GeNO LLC Description, Business Overview
5.5.3 GeNO LLC Nitric Oxide Therapy System Products Offered
5.5.4 GeNO LLC Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.5.5 GeNO LLC Nitric Oxide Therapy System Revenue by Product in 2024
5.5.6 GeNO LLC Nitric Oxide Therapy System Revenue by Application in 2024
5.5.7 GeNO LLC Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.5.8 GeNO LLC Recent Developments
5.6 International Biomedical
5.6.1 International Biomedical Corporation Information
5.6.2 International Biomedical Description, Business Overview
5.6.3 International Biomedical Nitric Oxide Therapy System Products Offered
5.6.4 International Biomedical Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.6.5 International Biomedical Nitric Oxide Therapy System Revenue by Product in 2024
5.6.6 International Biomedical Nitric Oxide Therapy System Revenue by Application in 2024
5.6.7 International Biomedical Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.6.8 International Biomedical Recent Developments
5.7 SLE
5.7.1 SLE Corporation Information
5.7.2 SLE Description, Business Overview
5.7.3 SLE Nitric Oxide Therapy System Products Offered
5.7.4 SLE Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.7.5 SLE Nitric Oxide Therapy System Revenue by Product in 2024
5.7.6 SLE Nitric Oxide Therapy System Revenue by Application in 2024
5.7.7 SLE Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.7.8 SLE Recent Developments
5.8 Mallinckrodt Pharmaceuticals
5.8.1 Mallinckrodt Pharmaceuticals Corporation Information
5.8.2 Mallinckrodt Pharmaceuticals Description, Business Overview
5.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Products Offered
5.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.8.5 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue by Product in 2024
5.8.6 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue by Application in 2024
5.8.7 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.8.8 Mallinckrodt Pharmaceuticals Recent Developments
5.9 Praxair,
5.9.1 Praxair, Corporation Information
5.9.2 Praxair, Description, Business Overview
5.9.3 Praxair, Nitric Oxide Therapy System Products Offered
5.9.4 Praxair, Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.9.5 Praxair, Nitric Oxide Therapy System Revenue by Product in 2024
5.9.6 Praxair, Nitric Oxide Therapy System Revenue by Application in 2024
5.9.7 Praxair, Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.9.8 Praxair, Recent Developments
5.10 Vapotherm
5.10.1 Vapotherm Corporation Information
5.10.2 Vapotherm Description, Business Overview
5.10.3 Vapotherm Nitric Oxide Therapy System Products Offered
5.10.4 Vapotherm Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.10.5 Vapotherm Nitric Oxide Therapy System Revenue by Product in 2024
5.10.6 Vapotherm Nitric Oxide Therapy System Revenue by Application in 2024
5.10.7 Vapotherm Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.10.8 Vapotherm Recent Developments
5.11 Linde Group
5.11.1 Linde Group Corporation Information
5.11.2 Linde Group Description, Business Overview
5.11.3 Linde Group Nitric Oxide Therapy System Products Offered
5.11.4 Linde Group Nitric Oxide Therapy System Revenue and Gross Margin (2020-2025)
5.11.5 Linde Group Nitric Oxide Therapy System Revenue by Product in 2024
5.11.6 Linde Group Nitric Oxide Therapy System Revenue by Application in 2024
5.11.7 Linde Group Nitric Oxide Therapy System Revenue by Geographic Area in 2024
5.11.8 Linde Group Recent Developments
6 North America
6.1 North America Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
6.2 North America Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
6.3 North America Nitric Oxide Therapy System Revenue by Type (2020-2025)
6.4 North America Nitric Oxide Therapy System Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Nitric Oxide Therapy System Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Nitric Oxide Therapy System Revenue by Type (2020-2025)
7.4 Asia-Pacific Nitric Oxide Therapy System Revenue by Application (2020-2025)
8 Europe
8.1 Europe Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
8.2 Europe Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
8.3 Europe Nitric Oxide Therapy System Revenue by Type (2020-2025)
8.4 Europe Nitric Oxide Therapy System Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
9.2 Latin America Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
9.3 Latin America Nitric Oxide Therapy System Revenue by Type (2020-2025)
9.4 Latin America Nitric Oxide Therapy System Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Nitric Oxide Therapy System Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Nitric Oxide Therapy System Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Nitric Oxide Therapy System Revenue by Type (2020-2025)
10.4 Middle East and Africa Nitric Oxide Therapy System Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Nitric Oxide Therapy System Supply Chain Analysis
11.2 Nitric Oxide Therapy System Key Raw Materials and Upstream Suppliers
11.3 Nitric Oxide Therapy System Clients Analysis
11.4 Nitric Oxide Therapy System Sales Channel and Sales Model Analysis
11.4.1 Nitric Oxide Therapy System Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Nitric Oxide Therapy System Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Nitric Oxide Therapy System Distributors
12 Nitric Oxide Therapy System Market Dynamics
12.1 Nitric Oxide Therapy System Industry Trends
12.2 Nitric Oxide Therapy System Market Drivers
12.3 Nitric Oxide Therapy System Market Challenges
12.4 Nitric Oxide Therapy System Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Nitric Oxide Therapy System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Nitric Oxide Therapy System Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Nitric Oxide Therapy System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nitric Oxide Therapy System Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Nitric Oxide Therapy System Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Nitric Oxide Therapy System Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Nitric Oxide Therapy System Revenue by Company (2020-2025) & (US$ Million)
Table 11. Nitric Oxide Therapy System Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Nitric Oxide Therapy System Players by Revenue (US$ Million) in 2024
Table 13. Global Nitric Oxide Therapy System Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Nitric Oxide Therapy System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitric Oxide Therapy System as of 2024)
Table 15. Global Nitric Oxide Therapy System Companies Headquarters
Table 16. Date of International Companies Enter into Nitric Oxide Therapy System Market
Table 17. Global Nitric Oxide Therapy System Companies Product & Service
Table 18. Global Nitric Oxide Therapy System Mergers & Acquisitions, Expansion Plans
Table 19. Bellerophon Therapeutics Corporation Information
Table 20. Bellerophon Therapeutics Description and Business Overview
Table 21. Bellerophon Therapeutics Nitric Oxide Therapy System Product
Table 22. Bellerophon Therapeutics Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Bellerophon Therapeutics Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 24. Bellerophon Therapeutics Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 25. Bellerophon Therapeutics Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 26. Bellerophon Therapeutics Recent Developments
Table 27. BOC Healthcare Corporation Information
Table 28. BOC Healthcare Description and Business Overview
Table 29. BOC Healthcare Nitric Oxide Therapy System Product
Table 30. BOC Healthcare Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. BOC Healthcare Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 32. BOC Healthcare Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 33. BOC Healthcare Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 34. BOC Healthcare Recent Developments
Table 35. Dan Hammer Health Corporation Information
Table 36. Dan Hammer Health Description and Business Overview
Table 37. Dan Hammer Health Nitric Oxide Therapy System Product
Table 38. Dan Hammer Health Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Dan Hammer Health Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 40. Dan Hammer Health Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 41. Dan Hammer Health Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 42. Dan Hammer Health Recent Developments
Table 43. EKU Elektronik GmbH Corporation Information
Table 44. EKU Elektronik GmbH Description and Business Overview
Table 45. EKU Elektronik GmbH Nitric Oxide Therapy System Product
Table 46. EKU Elektronik GmbH Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. EKU Elektronik GmbH Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 48. EKU Elektronik GmbH Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 49. EKU Elektronik GmbH Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 50. EKU Elektronik GmbH Recent Developments
Table 51. GeNO LLC Corporation Information
Table 52. GeNO LLC Description and Business Overview
Table 53. GeNO LLC Nitric Oxide Therapy System Product
Table 54. GeNO LLC Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. GeNO LLC Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 56. GeNO LLC Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 57. GeNO LLC Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 58. GeNO LLC Recent Developments
Table 59. International Biomedical Corporation Information
Table 60. International Biomedical Description and Business Overview
Table 61. International Biomedical Nitric Oxide Therapy System Product
Table 62. International Biomedical Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. International Biomedical Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 64. International Biomedical Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 65. International Biomedical Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 66. International Biomedical Recent Developments
Table 67. SLE Corporation Information
Table 68. SLE Description and Business Overview
Table 69. SLE Nitric Oxide Therapy System Product
Table 70. SLE Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. SLE Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 72. SLE Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 73. SLE Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 74. SLE Recent Developments
Table 75. Mallinckrodt Pharmaceuticals Corporation Information
Table 76. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 77. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product
Table 78. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Mallinckrodt Pharmaceuticals Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 80. Mallinckrodt Pharmaceuticals Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 81. Mallinckrodt Pharmaceuticals Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 82. Mallinckrodt Pharmaceuticals Recent Developments
Table 83. Praxair, Corporation Information
Table 84. Praxair, Description and Business Overview
Table 85. Praxair, Nitric Oxide Therapy System Product
Table 86. Praxair, Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Praxair, Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 88. Praxair, Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 89. Praxair, Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 90. Praxair, Recent Developments
Table 91. Vapotherm Corporation Information
Table 92. Vapotherm Description and Business Overview
Table 93. Vapotherm Nitric Oxide Therapy System Product
Table 94. Vapotherm Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Vapotherm Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 96. Vapotherm Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 97. Vapotherm Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 98. Vapotherm Recent Developments
Table 99. Linde Group Corporation Information
Table 100. Linde Group Description and Business Overview
Table 101. Linde Group Nitric Oxide Therapy System Product
Table 102. Linde Group Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Linde Group Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 104. Linde Group Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 105. Linde Group Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 106. Linde Group Recent Developments
Table 107. North America Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Nitric Oxide Therapy System Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Nitric Oxide Therapy System Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 127. Nitric Oxide Therapy System Key Raw Materials, Industry Status and Trend
Table 128. Nitric Oxide Therapy System Key Raw Materials and Upstream Suppliers
Table 129. Nitric Oxide Therapy System Clients Status and Trend
Table 130. Nitric Oxide Therapy System Typical Clients
Table 131. Nitric Oxide Therapy System Distributors
Table 132. Nitric Oxide Therapy System Market Trends
Table 133. Nitric Oxide Therapy System Market Drivers
Table 134. Nitric Oxide Therapy System Market Challenges
Table 135. Nitric Oxide Therapy System Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Nitric Oxide Therapy System Product Picture
Figure 2. Global Nitric Oxide Therapy System Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Nitric Oxide Therapy System Revenue Market Share by Type in 2024 & 2031
Figure 4. Protable System Product Picture
Figure 5. Fixed System Product Picture
Figure 6. Global Nitric Oxide Therapy System Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Nitric Oxide Therapy System Revenue Market Share by Application in 2024 & 2031
Figure 8. Hospitals
Figure 9. Homecare Settings
Figure 10. Others
Figure 11. Nitric Oxide Therapy System Report Years Considered
Figure 12. Global Nitric Oxide Therapy System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nitric Oxide Therapy System Market Size (2020-2031) & (US$ Million)
Figure 14. Global Nitric Oxide Therapy System Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Nitric Oxide Therapy System Revenue Market Share by Region (2020-2031)
Figure 16. Global Nitric Oxide Therapy System Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Nitric Oxide Therapy System Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Protable System of Nitric Oxide Therapy System Revenue Market Share by Application, 2024 VS 2031
Figure 19. Fixed System of Nitric Oxide Therapy System Revenue Market Share by Application, 2024 VS 2031
Figure 20. Nitric Oxide Therapy System Revenue Share by Company (2024)
Figure 21. Nitric Oxide Therapy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Protable System Revenue Proportion by Company in 2024
Figure 23. Fixed System Revenue Proportion by Company in 2024
Figure 24. North America Nitric Oxide Therapy System Revenue 2020-2031 (US$ Million)
Figure 25. North America Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 26. North America Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Nitric Oxide Therapy System Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Nitric Oxide Therapy System Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 31. Europe Nitric Oxide Therapy System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Nitric Oxide Therapy System Revenue Market Share by Country (2020-2031)
Figure 33. Europe Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 34. Europe Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Nitric Oxide Therapy System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Nitric Oxide Therapy System Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Nitric Oxide Therapy System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Nitric Oxide Therapy System Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 43. Nitric Oxide Therapy System Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Nitric Oxide Therapy System Raw Materials by Region in 2024
Figure 45. Nitric Oxide Therapy System Distribution Channels
Figure 46. Global Nitric Oxide Therapy System Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Nitric Oxide Therapy System Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Nitric Oxide Therapy System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Nitric Oxide Therapy System Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Nitric Oxide Therapy System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nitric Oxide Therapy System Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Nitric Oxide Therapy System Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Nitric Oxide Therapy System Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Nitric Oxide Therapy System Revenue by Company (2020-2025) & (US$ Million)
Table 11. Nitric Oxide Therapy System Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Nitric Oxide Therapy System Players by Revenue (US$ Million) in 2024
Table 13. Global Nitric Oxide Therapy System Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Nitric Oxide Therapy System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitric Oxide Therapy System as of 2024)
Table 15. Global Nitric Oxide Therapy System Companies Headquarters
Table 16. Date of International Companies Enter into Nitric Oxide Therapy System Market
Table 17. Global Nitric Oxide Therapy System Companies Product & Service
Table 18. Global Nitric Oxide Therapy System Mergers & Acquisitions, Expansion Plans
Table 19. Bellerophon Therapeutics Corporation Information
Table 20. Bellerophon Therapeutics Description and Business Overview
Table 21. Bellerophon Therapeutics Nitric Oxide Therapy System Product
Table 22. Bellerophon Therapeutics Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Bellerophon Therapeutics Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 24. Bellerophon Therapeutics Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 25. Bellerophon Therapeutics Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 26. Bellerophon Therapeutics Recent Developments
Table 27. BOC Healthcare Corporation Information
Table 28. BOC Healthcare Description and Business Overview
Table 29. BOC Healthcare Nitric Oxide Therapy System Product
Table 30. BOC Healthcare Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. BOC Healthcare Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 32. BOC Healthcare Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 33. BOC Healthcare Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 34. BOC Healthcare Recent Developments
Table 35. Dan Hammer Health Corporation Information
Table 36. Dan Hammer Health Description and Business Overview
Table 37. Dan Hammer Health Nitric Oxide Therapy System Product
Table 38. Dan Hammer Health Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Dan Hammer Health Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 40. Dan Hammer Health Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 41. Dan Hammer Health Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 42. Dan Hammer Health Recent Developments
Table 43. EKU Elektronik GmbH Corporation Information
Table 44. EKU Elektronik GmbH Description and Business Overview
Table 45. EKU Elektronik GmbH Nitric Oxide Therapy System Product
Table 46. EKU Elektronik GmbH Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. EKU Elektronik GmbH Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 48. EKU Elektronik GmbH Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 49. EKU Elektronik GmbH Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 50. EKU Elektronik GmbH Recent Developments
Table 51. GeNO LLC Corporation Information
Table 52. GeNO LLC Description and Business Overview
Table 53. GeNO LLC Nitric Oxide Therapy System Product
Table 54. GeNO LLC Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. GeNO LLC Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 56. GeNO LLC Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 57. GeNO LLC Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 58. GeNO LLC Recent Developments
Table 59. International Biomedical Corporation Information
Table 60. International Biomedical Description and Business Overview
Table 61. International Biomedical Nitric Oxide Therapy System Product
Table 62. International Biomedical Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. International Biomedical Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 64. International Biomedical Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 65. International Biomedical Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 66. International Biomedical Recent Developments
Table 67. SLE Corporation Information
Table 68. SLE Description and Business Overview
Table 69. SLE Nitric Oxide Therapy System Product
Table 70. SLE Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. SLE Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 72. SLE Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 73. SLE Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 74. SLE Recent Developments
Table 75. Mallinckrodt Pharmaceuticals Corporation Information
Table 76. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 77. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product
Table 78. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Mallinckrodt Pharmaceuticals Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 80. Mallinckrodt Pharmaceuticals Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 81. Mallinckrodt Pharmaceuticals Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 82. Mallinckrodt Pharmaceuticals Recent Developments
Table 83. Praxair, Corporation Information
Table 84. Praxair, Description and Business Overview
Table 85. Praxair, Nitric Oxide Therapy System Product
Table 86. Praxair, Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Praxair, Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 88. Praxair, Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 89. Praxair, Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 90. Praxair, Recent Developments
Table 91. Vapotherm Corporation Information
Table 92. Vapotherm Description and Business Overview
Table 93. Vapotherm Nitric Oxide Therapy System Product
Table 94. Vapotherm Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Vapotherm Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 96. Vapotherm Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 97. Vapotherm Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 98. Vapotherm Recent Developments
Table 99. Linde Group Corporation Information
Table 100. Linde Group Description and Business Overview
Table 101. Linde Group Nitric Oxide Therapy System Product
Table 102. Linde Group Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Linde Group Revenue Proportion of Nitric Oxide Therapy System by Product in 2024
Table 104. Linde Group Revenue Proportion of Nitric Oxide Therapy System by Application in 2024
Table 105. Linde Group Revenue Proportion of Nitric Oxide Therapy System by Geographic Area in 2024
Table 106. Linde Group Recent Developments
Table 107. North America Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Nitric Oxide Therapy System Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Nitric Oxide Therapy System Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Nitric Oxide Therapy System Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Nitric Oxide Therapy System Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Nitric Oxide Therapy System Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Nitric Oxide Therapy System Revenue by Application (2020-2025) & (US$ Million)
Table 127. Nitric Oxide Therapy System Key Raw Materials, Industry Status and Trend
Table 128. Nitric Oxide Therapy System Key Raw Materials and Upstream Suppliers
Table 129. Nitric Oxide Therapy System Clients Status and Trend
Table 130. Nitric Oxide Therapy System Typical Clients
Table 131. Nitric Oxide Therapy System Distributors
Table 132. Nitric Oxide Therapy System Market Trends
Table 133. Nitric Oxide Therapy System Market Drivers
Table 134. Nitric Oxide Therapy System Market Challenges
Table 135. Nitric Oxide Therapy System Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Nitric Oxide Therapy System Product Picture
Figure 2. Global Nitric Oxide Therapy System Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Nitric Oxide Therapy System Revenue Market Share by Type in 2024 & 2031
Figure 4. Protable System Product Picture
Figure 5. Fixed System Product Picture
Figure 6. Global Nitric Oxide Therapy System Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Nitric Oxide Therapy System Revenue Market Share by Application in 2024 & 2031
Figure 8. Hospitals
Figure 9. Homecare Settings
Figure 10. Others
Figure 11. Nitric Oxide Therapy System Report Years Considered
Figure 12. Global Nitric Oxide Therapy System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nitric Oxide Therapy System Market Size (2020-2031) & (US$ Million)
Figure 14. Global Nitric Oxide Therapy System Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Nitric Oxide Therapy System Revenue Market Share by Region (2020-2031)
Figure 16. Global Nitric Oxide Therapy System Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Nitric Oxide Therapy System Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Protable System of Nitric Oxide Therapy System Revenue Market Share by Application, 2024 VS 2031
Figure 19. Fixed System of Nitric Oxide Therapy System Revenue Market Share by Application, 2024 VS 2031
Figure 20. Nitric Oxide Therapy System Revenue Share by Company (2024)
Figure 21. Nitric Oxide Therapy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Protable System Revenue Proportion by Company in 2024
Figure 23. Fixed System Revenue Proportion by Company in 2024
Figure 24. North America Nitric Oxide Therapy System Revenue 2020-2031 (US$ Million)
Figure 25. North America Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 26. North America Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Nitric Oxide Therapy System Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Nitric Oxide Therapy System Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 31. Europe Nitric Oxide Therapy System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Nitric Oxide Therapy System Revenue Market Share by Country (2020-2031)
Figure 33. Europe Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 34. Europe Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Nitric Oxide Therapy System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Nitric Oxide Therapy System Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Nitric Oxide Therapy System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Nitric Oxide Therapy System Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Nitric Oxide Therapy System Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Nitric Oxide Therapy System Revenue Market Share by Application (2020-2025)
Figure 43. Nitric Oxide Therapy System Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Nitric Oxide Therapy System Raw Materials by Region in 2024
Figure 45. Nitric Oxide Therapy System Distribution Channels
Figure 46. Global Nitric Oxide Therapy System Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Nitric Oxide Therapy System Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232